Patent · US Active

Tetrazole derivatives as cytochrome P450 inhibitors

US10577333B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

C26 Bioscience AB · SE

Inventors

Leif Eriksson · Göteborg, SE
Allan Sirsjö · Örebro, SE
Åke Strid · Örebro, SE

Key dates

Filing date	Feb 10, 2017
Grant date	Mar 3, 2020
Priority date	—
Expiry date	Feb 10, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

According to the invention there is provided a compound of formula I, wherein R1 and R2 have meanings given in the description, which compounds are useful in the treatment of skin disorders and other diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.